Inhibition of oral streptococci growth induced by the complementary action of berberine chloride and antibacterial compounds

Molecules

Volumn 20, Issue 8, 2015, Pages 13705-13724

  Dziedzic, Arkadiusz ^a   Wojtyczka, Robert D Wojtyczka ^a   Kubina, Robert ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Antimicrobial activity; Berberine; MBC; MIC; Microdilution assay; Opportunistic infection; Oral streptococci

Indexed keywords

ANTIINFECTIVE AGENT; BERBERINE;

AGONISTS; CYTOLOGY; DRUG POTENTIATION; GROWTH, DEVELOPMENT AND AGING; HUMAN; MICROBIOLOGY; MOUTH; STREPTOCOCCUS;

ANTI-INFECTIVE AGENTS; BERBERINE; DRUG SYNERGISM; HUMANS; MOUTH; STREPTOCOCCUS;

EID: 84941588156     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules200813705     Document Type: Article

References (60)

1. Kreth, J.; Merritt, J.; Qi, F. Bacterial and Host Interactions of Oral Streptococci. DNA Cell Biol. 2009, 28, 397-403.
2. Avila, M.; Ojcius, D.M.; Yilmaz, Ö. The Oral Microbiota: Living with a Permanent Guest. DNA Cell Biol. 2009, 28, 405-411.
3. Aas, J.A.; Paster, B.J.; Stokes, L.N.; Olsen, I.; Dewhirst, F.E. Defining the Normal Bacterial Flora of the Oral Cavity. J. Clin. Microbiol. 2005, 43, 5721-5732.
4. Nicolas, G.G.; Lavoie, M.C. Streptococcus mutans and oral streptococci in dentalplaque. Can. J. Microbiol. 2011, 57, 1-20.
5. Wang, B.Y.; Kuramitsu, H.K. Interactions between oral bacteria: Inhibition of Streptococcus mutans bacteriocin production by Streptococcus gordonii. Appl. Environ. Microbiol. 2005, 71, 354-362.
6. Krzyœciak, W.; Jurczak, A.; Koœcielniak, D.; Bystrowska, B.; Skalniak, A. The virulence of Streptococcus mutans and the ability to form biofilms. Eur. J. Clin. Microbiol. Infect. Dis. 2013, 33, 499-515.
7. Loesche, W.J. Role of Streptococcus mutans in human dental decay. Microbiol. Rev. 1986, 50, 353-380.
8. Banas, J.A. Virulence properties of Streptococcus mutans. Front. Biosci. 2004, 19, 1267-1277.
9. Kreth, J.; Merritt, J.; Shi, W.; Qi, F. Competition and coexistence between Streptococcus mutans and Streptococcus sanguinis in the dental biofilm. J. Bacteriol. 2005, 187, 7193-7203.
10. Herzberg, M.C.; Gong, K.; MacFarlane, G.D.; Erickson, P.R.; Soberay, A.H.; Krebsbach, P.H.; Manjula, G.; Schilling, K.; Bowen, W.H. Phenotypic characterization of Streptococcus sanguis virulence factors associated with bacterial endocarditis. Infect. Immun. 1990, 58, 515-522.
11. Paik, S.; Senty, L.; Das, S.; Noe, J.C.; Munro, C.L.; Kitten, T. Identification of virulence determinants for endocarditis in Streptococcus sanguinis by signature-tagged mutagenesis. Infect. Immun. 2005, 73, S6064-S6074.
12. Biswas, S.; Bowler, I.C.; Bunch, C.; Prendergast, B.; Webster, D.P. Streptococcus mutans infective endocarditis complicated by vertebral discitis following dental treatment without antibiotic prophylaxis. J. Med. Microbiol. 2010, 59, 1257-1259.
13. Caufield, P.W.; Dasanayake, A.P.; Li, Y.; Pan, Y.; Hsu, J.; Hardin, J.M. Natural history of Streptococcus sanguinis in the oral cavity of infants: Evidence for a discrete window of infectivity. Infect. Immun. 2000, 68, 4018-4023.
14. Kuramitsu, H.K.; Wang, B.Y. The whole is greater than the sum of its parts: Dental plaque bacterial interactions can affect the virulence properties of cariogenic Streptococcus mutans. Am. J. Dent. 2011, 24, 153-154.
15. Do, T.; Jolley, K.A.; Maiden, M.C.J. Population structure of Streptococcus oralis. Microbiology 2009, 155, 2593-2602.
16. Huang, W.T.; Chang, L.Y.; Hsueh, P.R.; Lu, C.Y.; Shao, P.L.; Huang, F.Y.; Lee, P.I.; Chen, C.M.; Lee, C.Y.; Huang, L.M. Clinical features and complications of viridans streptococci bloodstream infection in pediatric hemato-oncology patients. J. Microbiol. Immunol. Infect. 2007, 40, 349-354.
17. Doyuk, E.; Ormerod, O.J.; Bowler, I.C. Native valve endocarditis due to Streptococcus vestibularis and Streptococcus oralis. J. Infect. 2002, 45, 39-41.
18. Renton, B.J.; Clague, J.E.; Cooke, R.P. Streptococcus oralis endocarditis presenting as infective discitis in an edentulous patient. Int. J. Cardiol. 2009, 137, e13-e14.
19. Whatmore, A.M.; Efstratiou, A.; Pickerill, A.P.; Broughton, K.; Woodard, G.; Sturgeon, D.; George, R.; Dowson, C.G. Genetic relationships between clinical isolates of Streptococcus pneumoniae, Streptococcus oralis, and Streptococcus mitis: Characterization of "Atypical" pneumococci and organisms allied to S. mitis harboring S. pneumoniae virulence factor-encoding genes. Infect. Immun. 2000, 68, 1374-1382.
20. Kennedy, H.F.; Morrison, D.; Tomlinson, D.; Gibson, B.E.; Bagg, J.; Gemmell, C.G. Gingivitis and toothbrushes: Potential roles in viridans streptococcal bacteraemia. J. Infect. 2003, 46, 67-70.
21. Maeda, K.; Nagata, H.; Kuboniwa, M.; Ojima, M.; Osaki, T.; Minamino, N.; Amano, A. Identification and Characterization of Porphyromonas gingivalis Client Proteins That Bind to Streptococcus oralis Glyceraldehyde-3-Phosphate Dehydrogenase. Infect. Immun. 2013, 81, 753-763.
22. Montejo, M.; Aguirrebeugere, K. Streptococcus oralis meningitis after dental manipulation. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 1998, 85, 126-127.
23. Wilson, W.; Taubert, K.A.; Gewitz, M.; Lockhart, P.B.; Baddour, L.M.; Levison, M.; Bolger, A.; Cabell, C.H.; Takahashi, M.; Baltimore, R.S.; et al. Prevention of infective endocarditis: Guidelines from the American Heart Association: A guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circultion 2007, 116, 1736-1754.
24. Centre for Clinical Practice. Prophylaxis against Infective Endocarditis. Antimicrobial Prophylaxis against Infective Endocarditis in Adults and Children Undergoing Interventional Procedures; NICE clinical guideline; National Institute for Health and Clinical Excellence: London, UK, 2008.
25. Vuddanda, P.R.; Chakraborty, S.; Singh, S. Berberine: A potential phytochemical with multispectrum therapeutic activities. Expert Opin. Investig. Drugs 2010, 19, 1297-1307.
26. Cernáková, M.; Kostálová, D. Antimicrobial activity of berberine-A constituent of Mahonia aquifolium. Folia Microbiol. 2002, 47, 375-378.
27. Freilea, M.L.; Giannini, F.; Pucci, G.; Sturniolo, A.; Rodero, L.; Pucci, O.; Balzareti, V.; Enriz, R.D. Antimicrobial activity of aqueous extracts and of berberine isolated from Berberis. Heterophylla Fitoter. 2003, 74, 602-705.
28. Cowan, M.M. Plant products as antimicrobial agents. Clin. Microbiol. Rev. 1999, 12, 564-582.
29. Park, K.S.; Kang, K.C.; Kim, J.H.; Adams, D.J.; Johng, T.N.; Paik Y.K. Differential inhibitory effects of protoberberines on sterol and chitin biosyntheses in Candida albicans. J. Antimicrob. Chemother. 1999, 43, 667-674.
30. Birdsall, T.C.; Kelly, G.S. Berberine: Therapeutic potential of an alkaloid found in several medicinal plants. Altern. Med. Rev. 1997, 2, 94-103.
31. Hu, J.P.; Takahashi, N.; Yamada, T. Coptidis rhizoma inhibits growth and proteases of oral bacteria. Oral Dis. 2000, 6, 297-302.
32. Rohrer, U.; Kunz, E.M.; Lenkeit, K.; Schaffner, W.; Meyer, J. Antimicrobial activity of Mahonia aquifolium and two of its alkaloids against oral bacteria. Schweiz. Mon. Zahnmed. 2007, 117, 1126-1131.
33. Hwang, B.Y.; Roberts, S.K.; Chadwick, L.R.; Wu, C.D.; Kinghorn, A.D. Antimicrobial constituents from goldenseal (the Rhizomes of Hydrastis canadensis) against selected oral pathogens. Planta Med. 2003, 69, 623-637.
34. Mogi, A.; Nishi, J.I.; Yoshinaga, M.; Harada, H.; Narahara, S.; Kawakami, K.; Maruyama, I. Increased prevalence of penicillin-resistant viridans group streptococci in Japanese children with upper respiratory infection treated by beta-lactam agents and in those with oncohematologic diseases. Pediatr. Infect. Dis. J. 1997, 16, 1140-1144.
35. Doern, G.V.; Ferraro, M.J.; Brueggemann, A.B.; Ruoff, K.L. Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States. Antimicrob. Agents Chemother. 1996, 40, 891-894.
36. Dziedzic, A.; Kubina, R.; Wojtyczka, R.D.; Kaba?a-Dzik, A.; Tanasiewicz, M.; Morawiec, T. The antibacterial effect of ethanol extract of polish propolis on mutans streptococci and lactobacilli isolated from saliva. Evid. Based Complement. Altern. Med. 2013, 2013, doi;10.1155/2013/681891.
37. Zuo, G.Y.; Li, Y.; Han, J.; Wang, G.C.; Zhang, Y.L.; Bian, Z.Q. Antibacterial and synergy of berberines with antibacterial agents against clinical multi-drug resistant isolates of Methicillin-Resistant Staphylococcus aureus (MRSA). Molecules 2012, 17, 10322-10330.
38. Yu, H.H.; Kim, K.J.; Cha, J.D.; Kim, H.K.; Lee, Y.E.; Choi, N.Y.; You, Y.O. Antimicrobial activity of berberine alone and in combination with ampicillin or oxacillin against methicillin-resistant Staphylococcus aureus. J. Med. Food 2005, 8, 454-461.
39. Wojtyczka, R.D.; Dziedzic, A.; Kêpa, M.; Kubina, R.; Kaba?a-Dzik, A.; Mularz, T.; Idzik, D. Berberine Enhances the Antibacterial Activity of Selected Antibiotics against Coagulase-Negative Staphylococcus Strains in Vitro. Molecules 2014, 19, 6583-6596.
40. Kinghorn, D.; Roberts, S.K.; Wu, C.D. Composition containing berberine or a derivative thereof and an antimicrobial agent or an antibiotic agent, and their use for treating oral pathogens and other disorders. Patent WO 2004093876 A2, 13 October 2005. Available online: http://www.google.com/patents/WO2004093876A2?cl=en (accessed on 27 July 2015).
41. Koh, J.; Wilson, M.; Vidic J.; Newman, H.N. Amoxycillin-resistant streptococci in dental plaque. Microbios 1986, 45, 41-53.
42. Hall, G.E.; Baddour, L.M. Apparent failure of endocarditis prophylaxis caused by penicillin-resistant Streptococcus mitis. Am. J. Med. Sci. 2002, 324, 51-53.
43. Masuda, K.; Nemoto, H.; Nakano, K.; Naka, S.; Nomura, R.; Ooshima, T. Amoxicillin-resistant oral streptococci identified in dental plaque specimens from healthy Japanese adults. J. Cardiol. 2012, 59, 285-290.
44. Nemoto, H.; Nomura, R.; Ooshima, T.; Nakano, K. Distribution of amoxicillin-resistant oral streptococci in dental plaque specimens obtained from Japanese children and adolescents at risk for infective endocarditis. J. Cardiol. 2013, 62, 296-300.
45. Palombo, E.A. Traditional Medicinal Plant Extracts and Natural Products with Activity against Oral Bacteria: Potential Application in the Prevention and Treatment of Oral Diseases. Evid. Based Complement. Altern. Med. 2011, 2011, doi:10.1093/ecam/nep067.
46. Wong, R.W.; Hägg, U.; Samaranayake, L.; Yuen, M.K.; Seneviratne, C.J.; Kao, R. Antimicrobial activity of Chinese medicine herbs against common bacteria in oral biofilm. A pilot study. Int. J. Oral Maxillofac. Surg. 2010, 39, 599-605.
47. Xie, Q.; Johnson, B.R.; Wenckus, C.S.; Fayad, M.I.; Wu, C.D. Efficacy of berberine, an antimicrobial plant alkaloid, as an endodontic irrigant against a mixed-culture biofilm in an in vitro tooth model. J. Endod. 2012, 38, 1114-1117.
48. Scazzocchio, F.; Cometa, M.F.; Tomassini, L.; Palmery, M. Antibacterial activity of Hydrastis canadensis extract and its major isolated alkaloids. Planta Med. 2001, 67, 561-564.
49. Ettefagh, K.A.; Burns, J.T.; Junio, H.A.; Kattz, G.W.; Cech, N.B. Goldenseal (Hydrastis canadensis L.) extracts synergistically enhance the antibacterial activity of berberine via efflux pump inhibition. Planta Med. 2011, 77, 835-840.
50. Stermitz, F.R.; Lorenz, P.; Tawara, J.N.; Zenewicz, L.A.; Lewis, K. Synergy in a medicinal plant: Antimicrobial action of berberine potentiated by 5?-methoxyhydnocarpin, a multidrug pump inhibitor. Proc. Natl. Acad. Sci. USA 2000, 97, 1433-1437.
51. Jin, J.L.; Hua, G.G.; Meng, Z.; Gao, P.J. Antibacterial mechanisms of berberine and reasons for little resistance of bacteria. Chin. Herb. Med. 2010, 3, 27-35.
52. Sun, N.; Chan, F.Y.; Lu, Y.J.; Neves, M.A.C.; Lui, H.K.; Wang, Y.; Chow, K.Y.; Chan, K.F.; Yan, S.C.; Leung, Y.C.; et al. Rational Design of Berberine-Based FtsZ Inhibitors with Broad-Spectrum Antibacterial Activity. PLoS ONE 2014, 9, e97514.
53. Amsterdam, D. Susceptibility Testing of Antimicrobials in Liquid Media. In Antibiotics in Laboratory Medicine, 5th ed.; Loman, V., Ed.; Williams and Wilkins: Philadelphia, PA, USA, 2005; pp. 61-143.
54. European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by broth dilution. Clin. Microbiol. Infect. 2003, 9, 1-7.
55. Devienne, K.F.; Raddi, M.S.G. Screening for antimicrobial activity of natural Products using a microplate photometer. Braz. J. Microbiol. 2002, 33, 166-168.
56. European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). Terminology relating to methods for the determination of susceptibility of bacteria to antimicrobial agents. EUCAST definitive document E. Def. 1.2. Clin. Microbiol. Infect. 2000, 6, 503-508.
57. Bär, W.; Bäde-Schumann, U.; Krebs, A.; Cromme, L. Rapid method for detection of minimal bactericidal concentration of antibiotics. J. Microbiol. Methods 2009, 77, 85-89.
58. Pettit, R.K.; Weber, C.A.; Kean, M.J.; Hoffmann, H.; Pettit, G.R.; Tan, R.; Franks, K.S.; Horton, M.L. Microplate Alamar Blue Assay for Staphylococcus epidermidis Biofilm Susceptibility Testing. Antimicrob. Agents Chemother. 2005, 49, 2612-2617.
59. Fernandes Junior, A.; Balestrin, E.C.; Betoni, J.E.C.; Orsi, R.O.; da Cunha, M.R.S.; Montelli, A.C. Propolis: Anti-Staphylococcus aureus activity and synergism with antimicrobial drugs. Mem. Inst. Oswaldo Cruz 2005, 100, 563-566.
60. Mahon, C.R.; Manuselis, J.R.G. Textbook of Diagnostic Microbiology; WB Saunders: Philadelphia, PA, USA, 1995; p. 1134.